Search
Pfizer Inc
PFEAdd to Watchlist
25.210USD
-0.700-2.70%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
143.34BMarket Cap
19.15P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Pfizer Inc is 6.81, ranking 124 out of 157 in the Pharmaceuticals industry. The average price target is 29.00, with a high of 37.54 and a low of 24.00.
Analyst Rating
Based on
32
analysts
Hold
Current Rating
29.062
Target Price
+12.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Pfizer Inc
PFE
32
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Pfizer Inc's expected revenue for the next quarter?
Pfizer Inc's expected revenue is 14.42B.
What is Pfizer Inc's price target?
Analysts forecast that Pfizer Inc's price target is USD 29.00, with the highest forecast at USD 37.54 and the lowest forecast at USD 24.00.
How have Pfizer IncPFE's recent earnings per share performed?
The market expectation was USD 0.47, while Pfizer IncPFE's earnings per share (EPS) for the previous quarter was USD -0.29. EPS for the next quarter is expected at USD 0.68.
What is the analyst rating for Pfizer Inc?
Based on the ratings of Pfizer Inc's stock from 32 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
